A citation-based method for searching scientific literature

Niels Eijkelkamp, John E Linley, Mark D Baker, Michael S Minett, Roman Cregg, Robert Werdehausen, François Rugiero, John N Wood. Brain 2012
Times Cited: 220







List of co-cited articles
546 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An SCN9A channelopathy causes congenital inability to experience pain.
James J Cox, Frank Reimann, Adeline K Nicholas, Gemma Thornton, Emma Roberts, Kelly Springell, Gulshan Karbani, Hussain Jafri, Jovaria Mannan, Yasmin Raashid,[...]. Nature 2006
981
17


Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist.
Shivani Ahuja, Susmith Mukund, Lunbin Deng, Kuldip Khakh, Elaine Chang, Hoangdung Ho, Stephanie Shriver, Clint Young, Sophia Lin, J P Johnson,[...]. Science 2015
191
12


Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
Ken McCormack, Sonia Santos, Mark L Chapman, Douglas S Krafte, Brian E Marron, Christopher W West, Michael J Krambis, Brett M Antonio, Shannon G Zellmer, David Printzenhoff,[...]. Proc Natl Acad Sci U S A 2013
162
10

Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release.
Aristos J Alexandrou, Adam R Brown, Mark L Chapman, Mark Estacion, Jamie Turner, Malgorzata A Mis, Anna Wilbrey, Elizabeth C Payne, Alex Gutteridge, Peter J Cox,[...]. PLoS One 2016
106
10

The Na(V)1.7 sodium channel: from molecule to man.
Sulayman D Dib-Hajj, Yang Yang, Joel A Black, Stephen G Waxman. Nat Rev Neurosci 2013
358
10

Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons.
Michael S Minett, Mohammed A Nassar, Anna K Clark, Gayle Passmore, Anthony H Dickenson, Fan Wang, Marzia Malcangio, John N Wood. Nat Commun 2012
190
10

Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy.
Catharina G Faber, Janneke G J Hoeijmakers, Hye-Sook Ahn, Xiaoyang Cheng, Chongyang Han, Jin-Sung Choi, Mark Estacion, Giuseppe Lauria, Els K Vanhoutte, Monique M Gerrits,[...]. Ann Neurol 2012
353
10


Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity.
Russell F Graceffa, Alessandro A Boezio, Jessica Able, Steven Altmann, Loren M Berry, Christiane Boezio, John R Butler, Margaret Chu-Moyer, Melanie Cooke, Erin F DiMauro,[...]. J Med Chem 2017
40
22

Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7.
Nigel A Swain, Dave Batchelor, Serge Beaudoin, Bruce M Bechle, Paul A Bradley, Alan D Brown, Bruce Brown, Ken J Butcher, Richard P Butt, Mark L Chapman,[...]. J Med Chem 2017
41
21

Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain.
Jacinthe Gingras, Sarah Smith, David J Matson, Danielle Johnson, Kim Nye, Lauren Couture, Elma Feric, Ruoyuan Yin, Bryan D Moyer, Matthew L Peterson,[...]. PLoS One 2014
107
8

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.
Y P Goldberg, J MacFarlane, M L MacDonald, J Thompson, M-P Dube, M Mattice, R Fraser, C Young, S Hossain, T Pape,[...]. Clin Genet 2007
320
8

Recent progress in sodium channel modulators for pain.
Sharan K Bagal, Mark L Chapman, Brian E Marron, Rebecca Prime, R Ian Storer, Nigel A Swain. Bioorg Med Chem Lett 2014
110
8

Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.
Thilo Focken, Shifeng Liu, Navjot Chahal, Maxim Dauphinais, Michael E Grimwood, Sultan Chowdhury, Ivan Hemeon, Paul Bichler, David Bogucki, Matthew Waldbrook,[...]. ACS Med Chem Lett 2016
53
15

Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy.
Aoibhinn McDonnell, Susie Collins, Zahid Ali, Laura Iavarone, Raulin Surujbally, Simon Kirby, Richard P Butt. Pain 2018
72
11


Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.
Mohammed A Nassar, L Caroline Stirling, Greta Forlani, Mark D Baker, Elizabeth A Matthews, Anthony H Dickenson, John N Wood. Proc Natl Acad Sci U S A 2004
453
7

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice.
Anthony J Roecker, Melissa Egbertson, Kristen L G Jones, Robert Gomez, Richard L Kraus, Yuxing Li, Amy Jo Koser, Mark O Urban, Rebecca Klein, Michelle Clements,[...]. Bioorg Med Chem Lett 2017
27
25

Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.
Y Yang, Y Wang, S Li, Z Xu, H Li, L Ma, J Fan, D Bu, B Liu, Z Fan,[...]. J Med Genet 2004
525
7

Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain.
Yong-Jin Wu, Jason Guernon, Jianliang Shi, Jonathan Ditta, Kevin J Robbins, Ramkumar Rajamani, Amy Easton, Amy Newton, Clotilde Bourin, Kathleen Mosure,[...]. J Med Chem 2017
25
28

Nomenclature of voltage-gated sodium channels.
A L Goldin, R L Barchi, J H Caldwell, F Hofmann, J R Howe, J C Hunter, R G Kallen, G Mandel, M H Meisler, Y B Netter,[...]. Neuron 2000
566
7


Resurgent current of voltage-gated Na(+) channels.
Amanda H Lewis, Indira M Raman. J Physiol 2014
78
7

The roles of sodium channels in nociception: Implications for mechanisms of pain.
Theodore R Cummins, Patrick L Sheets, Stephen G Waxman. Pain 2007
333
6

ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors.
William A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, Timothy Bailey, Martin G Kohler, Adam B Weinglass, Gregory J Kaczorowski, Maria L Garcia, Martin Koltzenburg, Birgit T Priest. Mol Pharmacol 2008
215
6

Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current.
Tina M Grieco, Jyoti D Malhotra, Chunling Chen, Lori L Isom, Indira M Raman. Neuron 2005
179
6

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model.
Joseph E Pero, Michael A Rossi, Hannah D G F Lehman, Michael J Kelly, James J Mulhearn, Scott E Wolkenberg, Matthew J Cato, Michelle K Clements, Christopher J Daley, Tracey Filzen,[...]. Bioorg Med Chem Lett 2017
24
25

The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Shaoyi Sun, Qi Jia, Alla Y Zenova, Mikhail Chafeev, Zaihui Zhang, Sophia Lin, Rainbow Kwan, Mike E Grimwood, Sultan Chowdhury, Clint Young,[...]. Bioorg Med Chem Lett 2014
31
19

Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
Stephen G Waxman, Ingemar S J Merkies, Monique M Gerrits, Sulayman D Dib-Hajj, Giuseppe Lauria, James J Cox, John N Wood, C Geoffrey Woods, Joost P H Drenth, Catharina G Faber. Lancet Neurol 2014
117
6

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Michael F Jarvis, Prisca Honore, Char-Chang Shieh, Mark Chapman, Shailen Joshi, Xu-Feng Zhang, Michael Kort, William Carroll, Brian Marron, Robert Atkinson,[...]. Proc Natl Acad Sci U S A 2007
369
5

Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.
Frank H Yu, Massimo Mantegazza, Ruth E Westenbroek, Carol A Robbins, Franck Kalume, Kimberly A Burton, William J Spain, G Stanley McKnight, Todd Scheuer, William A Catterall. Nat Neurosci 2006
692
5

Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.
Massimo Mantegazza, Giulia Curia, Giuseppe Biagini, David S Ragsdale, Massimo Avoli. Lancet Neurol 2010
296
5

Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain.
Joel A Black, Shujun Liu, Masaki Tanaka, Theodore R Cummins, Stephen G Waxman. Pain 2004
295
5

Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses.
J H Caldwell, K L Schaller, R S Lasher, E Peles, S R Levinson. Proc Natl Acad Sci U S A 2000
480
5

Sodium currents in mesencephalic trigeminal neurons from Nav1.6 null mice.
Akifumi Enomoto, Juliette M Han, Chie-Fang Hsiao, Scott H Chandler. J Neurophysiol 2007
52
9

Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.
Jan Weiss, Martina Pyrski, Eric Jacobi, Bernd Bufe, Vivienne Willnecker, Bernhard Schick, Philippe Zizzari, Samuel J Gossage, Charles A Greer, Trese Leinders-Zufall,[...]. Nature 2011
189
5

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement.
Isaac E Marx, Thomas A Dineen, Jessica Able, Christiane Bode, Howard Bregman, Margaret Chu-Moyer, Erin F DiMauro, Bingfan Du, Robert S Foti, Robert T Fremeau,[...]. ACS Med Chem Lett 2016
27
18

The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
Wentao Wu, Zhixiang Li, Guangwen Yang, Mingxing Teng, Jian Qin, Zhijing Hu, Lijuan Hou, Liang Shen, Haiheng Dong, Yang Zhang,[...]. Bioorg Med Chem Lett 2017
11
45

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities.
Matthew M Weiss, Thomas A Dineen, Isaac E Marx, Steven Altmann, Alessandro Boezio, Howard Bregman, Margaret Chu-Moyer, Erin F DiMauro, Elma Feric Bojic, Robert S Foti,[...]. J Med Chem 2017
28
17

Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes.
R Ian Storer, Andy Pike, Nigel A Swain, Aristos J Alexandrou, Bruce M Bechle, David C Blakemore, Alan D Brown, Neil A Castle, Matthew S Corbett, Neil J Flanagan,[...]. Bioorg Med Chem Lett 2017
18
27

Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.
Edward C Emery, Ana Paula Luiz, John N Wood. Expert Opin Ther Targets 2016
117
5

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Justin K Murray, Joseph Ligutti, Dong Liu, Anruo Zou, Leszek Poppe, Hongyan Li, Kristin L Andrews, Bryan D Moyer, Stefan I McDonough, Philippe Favreau,[...]. J Med Chem 2015
92
4

Sodium channels in normal and pathological pain.
Sulayman D Dib-Hajj, Theodore R Cummins, Joel A Black, Stephen G Waxman. Annu Rev Neurosci 2010
425
4

A stop codon mutation in SCN9A causes lack of pain sensation.
Sultan Ahmad, Leif Dahllund, Anders B Eriksson, Dennis Hellgren, Urban Karlsson, Per-Eric Lund, Inge A Meijer, Luc Meury, Tracy Mills, Adrian Moody,[...]. Hum Mol Genet 2007
137
4

Na Channel β Subunits: Overachievers of the Ion Channel Family.
William J Brackenbury, Lori L Isom. Front Pharmacol 2011
197
4

Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons.
J J Toledo-Aral, B L Moss, Z J He, A G Koszowski, T Whisenand, S R Levinson, J J Wolf, I Silos-Santiago, S Halegoua, G Mandel. Proc Natl Acad Sci U S A 1997
394
4




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.